Market revenue in 2023 | USD 20.0 million |
Market revenue in 2030 | USD 43.5 million |
Growth rate | 11.8% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58% in 2023. Horizon Databook has segmented the India deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
India is anticipated to be the most prominent deep brain stimulation devices market owing to the increase in prevalence of brain-associated disorders such as PD and epilepsy. Moreover, the geriatric population is more susceptible to neurological disorders such as PD, brain stroke, OCD, and epilepsy.
Thus, the incidence of such disorders is expected to increase in the next 10 years, which is likely to create growth opportunities in deep brain stimulation devices market over the forecast period. In addition, growing need for quality healthcare and lack of matching delivery mechanisms are not only challenges in this field but also growth opportunities in the market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account